BioAmber Company Profile (NYSE:BIOA)

About BioAmber (NYSE:BIOA)

BioAmber logoBioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: Specialty Chemicals - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:BIOA
  • CUSIP: N/A
  • Web: www.bio-amber.com
Capitalization:
  • Market Cap: $78.22 million
  • Outstanding Shares: 37,073,000
Average Prices:
  • 50 Day Moving Avg: $2.48
  • 200 Day Moving Avg: $2.90
  • 52 Week Range: $1.88 - $6.50
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.17
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $8.94 million
  • Price / Sales: 8.75
  • Book Value: $1.87 per share
  • Price / Book: 1.13
Profitability:
  • EBIDTA: ($24,410,000.00)
  • Net Margins: -127.85%
  • Return on Equity: -59.01%
  • Return on Assets: -21.42%
Debt:
  • Debt-to-Equity Ratio: 0.46%
  • Current Ratio: 1.19%
  • Quick Ratio: 0.91%
Misc:
  • Average Volume: 78,035 shs.
  • Beta: 2.61
  • Short Ratio: 8.11
 
Frequently Asked Questions for BioAmber (NYSE:BIOA)

What is BioAmber's stock symbol?

BioAmber trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIOA."

How were BioAmber's earnings last quarter?

BioAmber Inc. (NYSE:BIOA) issued its quarterly earnings data on Tuesday, May, 9th. The company reported ($0.31) EPS for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.18. The company had revenue of $2.12 million for the quarter, compared to analyst estimates of $3.65 million. BioAmber had a negative return on equity of 59.01% and a negative net margin of 127.85%. View BioAmber's Earnings History.

When will BioAmber make its next earnings announcement?

BioAmber is scheduled to release their next quarterly earnings announcement on Monday, August, 7th 2017. View Earnings Estimates for BioAmber.

Where is BioAmber's stock going? Where will BioAmber's stock price be in 2017?

2 analysts have issued 12-month price targets for BioAmber's shares. Their forecasts range from $3.00 to $5.50. On average, they anticipate BioAmber's share price to reach $4.25 in the next year. View Analyst Ratings for BioAmber.

Who are some of BioAmber's key competitors?

Who are BioAmber's key executives?

BioAmber's management team includes the folowing people:

  • Raymond J. Land, Chairman of the Board
  • Fabrice Orecchioni, President, Chief Operating Officer
  • Mario Settino, Chief Financial Officer
  • Michael A. Hartmann, Executive Vice President
  • James Millis, Chief Technology Officer
  • Robert Frost, Director
  • Kurt W. Briner, Independent Director
  • Heinz Haller, Independent Director
  • Ellen B. Richstone, Independent Director
  • Kenneth W Wall, Independent Director

Who owns BioAmber stock?

BioAmber's stock is owned by many different of institutional and retail investors. Top institutional investors include NN Investment Partners Holdings N.V. (7.73%). Company insiders that own BioAmber stock include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Michael A Hartmann and Raymond J Land. View Institutional Ownership Trends for BioAmber.

Who bought BioAmber stock? Who is buying BioAmber stock?

BioAmber's stock was acquired by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V.. Company insiders that have bought BioAmber stock in the last two years include George Frederick John Gosbee, Jean-Francois Huc, Kenneth W Wall, Kurt W Briner, Michael A Hartmann and Raymond J Land. View Insider Buying and Selling for BioAmber.

How do I buy BioAmber stock?

Shares of BioAmber can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioAmber's stock price today?

One share of BioAmber stock can currently be purchased for approximately $2.11.


MarketBeat Community Rating for BioAmber (NYSE BIOA)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about BioAmber and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for BioAmber (NYSE:BIOA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.25 (101.42% upside)

Analysts' Ratings History for BioAmber (NYSE:BIOA)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/17/2017Cowen and CompanySet Price TargetHold$3.00HighView Rating Details
3/13/2017AltaCorp CapitalDowngradeOutperform -> SpeculativeMediumView Rating Details
8/7/2016Canaccord GenuityReiterated RatingBuy$5.50N/AView Rating Details
3/28/2016Credit Suisse GroupBoost Price TargetOutperform$15.00 -> $17.00N/AView Rating Details
1/5/2016HC WainwrightReiterated RatingBuy$18.00N/AView Rating Details
1/5/2016Rodman & RenshawInitiated CoverageBuy$18.00N/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for BioAmber (NYSE:BIOA)
Earnings by Quarter for BioAmber (NYSE:BIOA)
Earnings History by Quarter for BioAmber (NYSE BIOA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2017($0.13)N/AView Earnings Details
5/9/20173/31/2017($0.13)($0.31)$3.65 million$2.12 millionViewListenView Earnings Details
3/16/201712/31/2016($0.19)($0.31)$3.77 million$0.63 millionViewN/AView Earnings Details
11/3/2016Q216($0.22)($0.26)$3.75 million$3.66 millionViewN/AView Earnings Details
8/9/2016Q116($0.27)($0.25)$2.37 million$2.50 millionViewN/AView Earnings Details
3/14/2016Q415($0.35)($0.40)$0.98 million$1.11 millionViewN/AView Earnings Details
11/4/2015Q315($0.41)($0.27)$2.30 million$0.35 millionViewN/AView Earnings Details
3/12/2015Q414($0.39)($0.48)($0.31) millionViewN/AView Earnings Details
11/6/2014Q3 2014($0.40)($0.41)$0.47 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.40)$0.40$0.45 million$0.42 millionViewN/AView Earnings Details
3/13/2014($0.36)($0.45)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for BioAmber (NYSE:BIOA)
Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $-0.23 EPS

Dividends

Dividend History for BioAmber (NYSE:BIOA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for BioAmber (NYSE:BIOA)
Insider Ownership Percentage: 8.33%
Institutional Ownership Percentage: 45.93%
Insider Trades by Quarter for BioAmber (NYSE:BIOA)
Institutional Ownership by Quarter for BioAmber (NYSE:BIOA)
Insider Trades by Quarter for BioAmber (NYSE:BIOA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2016George Frederick John GosbeeDirectorBuy25,000$3.87$96,750.00View SEC Filing  
11/8/2016Kurt W BrinerDirectorBuy10,000$3.84$38,400.00View SEC Filing  
5/24/2016Kurt W BrinerDirectorBuy1,000$3.69$3,690.00View SEC Filing  
5/23/2016Kurt W BrinerDirectorBuy21,015$3.61$75,864.15View SEC Filing  
5/11/2016Jean-Francois HucCEOBuy10,000$3.22$32,200.00View SEC Filing  
5/9/2016Kenneth W WallDirectorBuy13,227$3.11$41,135.97View SEC Filing  
5/6/2016Michael A HartmannEVPBuy3,000$3.44$10,320.00View SEC Filing  
12/3/2015Jean-Francois HucCEOSell27,278$8.11$221,224.58View SEC Filing  
12/3/2015Michael A. HartmannEVPSell21,477$8.11$174,178.47View SEC Filing  
8/14/2015Michael A HartmannEVPBuy1,500$6.75$10,125.00View SEC Filing  
8/11/2015Jean-Francois HucCEOBuy4,000$6.18$24,720.00View SEC Filing  
8/10/2015Raymond J LandDirectorBuy1,500$6.71$10,065.00View SEC Filing  
5/6/2015Jean-Francois HucCEOBuy8,800$9.00$79,200.00View SEC Filing  
5/6/2015Kurt W BrinerDirectorBuy10,000$9.00$90,000.00View SEC Filing  
5/6/2015Michael A HartmannEVPBuy1,100$9.00$9,900.00View SEC Filing  
12/11/2014Kenneth W WallDirectorBuy3,000$9.20$27,600.00View SEC Filing  
12/10/2014Kenneth W WallDirectorBuy5,000$9.30$46,500.00View SEC Filing  
11/10/2014Kurt W BrinerDirectorBuy15,000$9.35$140,250.00View SEC Filing  
9/9/2014Kurt W BrinerDirectorBuy5,000$12.00$60,000.00View SEC Filing  
8/25/2014Kurt W BrinerDirectorBuy14,250$11.50$163,875.00View SEC Filing  
8/11/2014Kurt W BrinerDirectorBuy2,980$11.45$34,121.00View SEC Filing  
7/16/2014Jean-Francois HucCEOBuy4,000$12.00$48,000.00View SEC Filing  
7/16/2014Michael A HartmannEVPBuy3,000$12.00$36,000.00View SEC Filing  
5/12/2014Andrew P AshworthCFOBuy3,000$10.00$30,000.00View SEC Filing  
5/12/2014Michael A HartmannEVPBuy2,500$10.05$25,125.00View SEC Filing  
11/14/2013Kurt W BrinerDirectorBuy7,200$6.95$50,040.00View SEC Filing  
9/3/2013Michael A HartmannEVPBuy2,000$4.63$9,260.00View SEC Filing  
8/29/2013Jean-Francois HucCEOBuy5,000$4.25$21,250.00View SEC Filing  
8/15/2013Kurt W BrinerDirectorBuy13,000$5.49$71,370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for BioAmber (NYSE:BIOA)
Latest Headlines for BioAmber (NYSE:BIOA)
Source:
DateHeadline
americanbankingnews.com logoBioAmber Inc. (NYSE:BIOA) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - July 26 at 5:02 PM
prnewswire.com logoGlobal Bio-Based Chemicals Market Forecast 2017-2025 - PR Newswire (press release)
www.prnewswire.com - July 20 at 11:11 PM
finanznachrichten.de logoSuccinic Acid - Global Strategic Business Report 2017 - Rising Demand for Bio-Plastics: Opportunity for Bio-Succinic Acid Market
www.finanznachrichten.de - July 16 at 9:11 PM
americanbankingnews.com logoBioAmber Inc. (BIOA) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 11 at 7:14 PM
americanbankingnews.com logoComparing BioAmber (NYSE:BIOA) and Kraton Corporation (KRA)
www.americanbankingnews.com - July 9 at 8:22 AM
americanbankingnews.com logoBioAmber (NYSE:BIOA) & Rayonier Advanced Materials (RYAM) Head-To-Head Comparison
www.americanbankingnews.com - July 7 at 8:06 AM
americanbankingnews.com logoBioAmber Inc. (BIOA) Lifted to Sell at ValuEngine
www.americanbankingnews.com - June 24 at 12:38 AM
streetinsider.com logoBioAmber (BIOA) Announces Launch of BIO-SA Pharmaceutical Grade - StreetInsider.com
www.streetinsider.com - June 16 at 4:39 PM
streetinsider.com logoBioAmber (BIOA) Announces Launch of BIO-SA Pharmaceutical Grade
www.streetinsider.com - June 15 at 5:43 PM
finance.yahoo.com logoBioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid
finance.yahoo.com - June 15 at 5:43 PM
americanbankingnews.com logoBioAmber Inc. (BIOA) Lowered to "Strong Sell" at ValuEngine
www.americanbankingnews.com - June 12 at 12:40 AM
marketwatch.com logoTMX Group Equity Financing Statistics - May 2017
www.marketwatch.com - June 7 at 4:12 PM
finanznachrichten.de logoGlobal Organic Acid Market, Competition Forecast and Opportunities, 2026 - Research and Markets
www.finanznachrichten.de - May 29 at 9:13 AM
prnewswire.com logoBioAmber Announces Changes to its Board of Directors, the Appointment of a Chief Financial Officer and the Results ... - PR Newswire (press release)
www.prnewswire.com - May 17 at 8:59 PM
businesswire.com logoLaw Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff ... - Business Wire (press release)
www.businesswire.com - May 17 at 8:59 PM
finance.yahoo.com logoLaw Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead Plaintiff Deadline
finance.yahoo.com - May 16 at 4:00 PM
finance.yahoo.com logoBIOA DEADLINE ALERT: The Law Offices of Vincent Wong Notifies Investors of BioAmber Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA
finance.yahoo.com - May 16 at 4:00 PM
finance.yahoo.com logoBIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important May 17 Deadline in First Filed Class Action - BIOA
finance.yahoo.com - May 16 at 12:37 PM
finance.yahoo.com logoDEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 16 at 12:37 PM
americanbankingnews.com logoBioamber Inc (BIOA) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - May 15 at 4:28 PM
streetinsider.com logoBioAmber (BIOA) Names New CFO and Announces Changes to Board of Directors
www.streetinsider.com - May 15 at 4:04 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against BioAmber Inc. (BIOA) & Lead Plaintiff Deadline: May 17, 2017
finance.yahoo.com - May 15 at 4:04 PM
finance.yahoo.com logo2-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 15 at 4:04 PM
finance.yahoo.com logoUPCOMING DEADLINE ALERT: Levi & Korsinsky, LLP Reminds Shareholders of BioAmber Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA
finance.yahoo.com - May 15 at 4:04 PM
reuters.com logoBRIEF-BioAmber says Mario Settino appointed CFO
www.reuters.com - May 15 at 9:31 AM
finance.yahoo.com logoBioAmber Announces Changes to its Board of Directors, the Appointment of a Chief Financial Officer and the Results of its Annual Stockholders Meeting
finance.yahoo.com - May 15 at 9:31 AM
seekingalpha.com logoBioAmber (BIOA) Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 14 at 4:03 PM
finance.yahoo.com logo5-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 13 at 2:32 AM
finance.yahoo.com logoBIOA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of BioAmber Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA
finance.yahoo.com - May 12 at 4:30 PM
finance.yahoo.com logoBioAmber, Inc. :BIOA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
finance.yahoo.com - May 12 at 4:30 PM
finance.yahoo.com logo6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 11 at 9:30 PM
finance.yahoo.com logoONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 11 at 2:11 AM
finance.yahoo.com logoEdited Transcript of BIOA earnings conference call or presentation 9-May-17 8:30pm GMT
finance.yahoo.com - May 10 at 9:10 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of BioAmber Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 17, 2017 - BIOA
finance.yahoo.com - May 10 at 4:09 PM
americanbankingnews.com logoBioamber Inc (BIOA) Posts Earnings Results, Misses Estimates By $0.18 EPS
www.americanbankingnews.com - May 10 at 1:30 PM
prnewswire.com logoBioAmber Reports First Quarter 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - May 10 at 8:48 AM
finance.yahoo.com logoBioAmber Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 9 at 8:58 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Those with Losses in Excess of $100,000 from Investment in BioAmber Inc. to Contact the Firm
finance.yahoo.com - May 9 at 8:58 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 9 at 8:58 PM
finance.yahoo.com logoBioAmber posts 1Q profit
finance.yahoo.com - May 9 at 8:58 PM
finance.yahoo.com logoBIOA Investors: GPM Reminds Investors of the May 17 Deadline in the Class Action Lawsuit Against BioAmber Inc.
finance.yahoo.com - May 9 at 3:56 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of BioAmber Inc. Shareholders and a Lead Plaintiff Deadline of May 17, 2017 (BIOA)
finance.yahoo.com - May 9 at 3:56 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 8 at 8:49 PM
americanbankingnews.com logoBioamber Inc (BIOA) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - May 7 at 7:16 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 6 at 1:59 AM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against BioAmber Inc. (BIOA) and Lead Plaintiff Deadline: May 17, 2017
finance.yahoo.com - May 5 at 3:56 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Extremely Likely to Affect Bioamber (BIOA) Share Price
www.americanbankingnews.com - May 4 at 9:42 AM
marketwatch.com logoBioAmber Announces Trading on Toronto Stock Exchange Market Commencing on May 3, 2017 - Special Warrant ... - MarketWatch
www.marketwatch.com - May 3 at 6:13 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds ... - Yahoo Finance
finance.yahoo.com - May 3 at 6:13 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 3 at 6:13 PM

Social

Chart

BioAmber (BIOA) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff